Applied Genetic Tech (NASDAQ:AGTC) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35) by 14.29 percent. This is a 33.33 percent increase over losses of $(0.60) per share from the same period last year.
Barclays Initiates Coverage On Enphase Energy with Equal-Weight Rating, Announces Price Target of $292
Barclays analyst Christine Cho initiates coverage on Enphase Energy (NASDAQ:ENPH) with a Equal-Weight rating and announces Price Target of $292.
